5 Most Promising Micro-Cap Stocks According to Analysts

In this article, we will take a look at the 5 most promising micro-cap stocks according to analysts. To see more such companies, go directly to 12 Most Promising Micro-Cap Stocks According to Analysts.

5. OptimizeRx Corporation (NASDAQ:OPRX)

Number of Hedge Fund Holders: 15

One-Year Average Price Target: $26.17

OptimizeRx Corporation (NASDAQ:OPRX) is a digital health technology company. OptimizeRx Corporation (NASDAQ:OPRX) ranks 5th in our list of the most promising micro-cap stocks according to analysts. In November, OptimizeRx Corporation (NASDAQ:OPRX) posted its third-quarter results. Adjusted EPS in the period came in at $0.07, beating estimates by $0.03. Revenue in the quarter fell 6.3% on a YoY basis to total of $15.1 million but still beat estimates by $0.08 million. OptimizeRx Corporation (NASDAQ:OPRX) said its gross profit in the quarter increased by 4% on a YoY basis. Cash, cash equivalents and short-term investments totaled $78.8 million as of the end of the third quarter of 2022.

Artisan Partners made the following comment about OptimizeRx Corporation (NASDAQ:OPRX) in its Q3 2022 investor letter:

“OptimizeRx Corporation (NASDAQ:OPRX) offers a platform of digital communications solutions between pharma companies and both prescribing physicians and patients. The company’s vast network of electronic health record partners/integrations enables pharma companies to more intelligently target and directly communicate to physicians about important clinical and financial information, leading to better prescribing decisions. Unfortunately, pharmaceutical companies have been dialing back their digital marketing spend given the waning macro backdrop, which has negatively impacted OptimizeRx’s profit cycle. Given our lack of visibility into when these headwinds will abate, we exited our position.”